Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial
Titel:
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial
Auteur:
Cella, David Motzer, Robert J Suarez, Cristina Blum, Steven I Ejzykowicz, Flavia Hamilton, Melissa Wallace, Joel F Simsek, Burcin Zhang, Joshua Ivanescu, Cristina Apolo, Andrea B Choueiri, Toni K